Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093002
Status:
COMPLETED
Last Update Posted:
2008-06-12
First Post:
2004-09-28
Brief Title:
Fulvestrant FASLODEX as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Sponsor:
Organization:
AstraZeneca